脊髓样肉瘤1例。

Surgical neurology international Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI:10.25259/SNI_640_2024
Wouter Deconinck, Sven Bamps, Thomas Steelandt, Maarten Wissels, Mark Plazier, Eric Put, Salah-Eddine Achahbar, Steven Vanvolsem, Sacha Meeuws, Sam Klein, Gert Roosen
{"title":"脊髓样肉瘤1例。","authors":"Wouter Deconinck, Sven Bamps, Thomas Steelandt, Maarten Wissels, Mark Plazier, Eric Put, Salah-Eddine Achahbar, Steven Vanvolsem, Sacha Meeuws, Sam Klein, Gert Roosen","doi":"10.25259/SNI_640_2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Myeloid sarcoma (MS), a rare extramedullary tumor composed of myeloid blast cells, is classified by the World Health Organization as a subtype of acute myeloid leukemia (AML). Isolated, primary, or nonleukemic MS has an incidence of 2/1,000,000 adults and constitutes only 0.7% of all AML cases. MS presentations vary widely, with spinal involvement being rare.</p><p><strong>Case description: </strong>A-year-old male presented with interscapular pain radiating to the right upper arm/neck but was neurologically intact. Once diagnosed with isolated spinal MS, he underwent a surgical decompression followed by local irradiation, systemic chemotherapy, and bone marrow transplantation. Eight months postoperatively, however, he experienced a graft-versus-host rejection and required additional therapies.</p><p><strong>Conclusion: </strong>Establishing the diagnosis of MS is challenging and typically requires histological confirmation (i.e., the presence of myeloblasts and granulocytic cells). However, optimal treatment strategies remain elusive; despite radiation, chemotherapy, bone marrow transplant/other local therapies, the overall long-term prognosis for MS remains poor.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"15 ","pages":"415"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11618787/pdf/","citationCount":"0","resultStr":"{\"title\":\"A rare case of spinal myeloid sarcoma.\",\"authors\":\"Wouter Deconinck, Sven Bamps, Thomas Steelandt, Maarten Wissels, Mark Plazier, Eric Put, Salah-Eddine Achahbar, Steven Vanvolsem, Sacha Meeuws, Sam Klein, Gert Roosen\",\"doi\":\"10.25259/SNI_640_2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Myeloid sarcoma (MS), a rare extramedullary tumor composed of myeloid blast cells, is classified by the World Health Organization as a subtype of acute myeloid leukemia (AML). Isolated, primary, or nonleukemic MS has an incidence of 2/1,000,000 adults and constitutes only 0.7% of all AML cases. MS presentations vary widely, with spinal involvement being rare.</p><p><strong>Case description: </strong>A-year-old male presented with interscapular pain radiating to the right upper arm/neck but was neurologically intact. Once diagnosed with isolated spinal MS, he underwent a surgical decompression followed by local irradiation, systemic chemotherapy, and bone marrow transplantation. Eight months postoperatively, however, he experienced a graft-versus-host rejection and required additional therapies.</p><p><strong>Conclusion: </strong>Establishing the diagnosis of MS is challenging and typically requires histological confirmation (i.e., the presence of myeloblasts and granulocytic cells). However, optimal treatment strategies remain elusive; despite radiation, chemotherapy, bone marrow transplant/other local therapies, the overall long-term prognosis for MS remains poor.</p>\",\"PeriodicalId\":94217,\"journal\":{\"name\":\"Surgical neurology international\",\"volume\":\"15 \",\"pages\":\"415\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11618787/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical neurology international\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/SNI_640_2024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical neurology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/SNI_640_2024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:髓系肉瘤(MS)是一种罕见的髓系外肿瘤,由髓系母细胞组成,被世界卫生组织归类为急性髓系白血病(AML)的一个亚型。孤立性、原发性或非白血病性MS的发病率为2/ 100万成人,仅占所有AML病例的0.7%。多发性硬化症的表现多种多样,很少累及脊柱。病例描述:a岁男性,表现为肩胛间疼痛,放射至右上臂/颈部,但神经系统完好。一旦确诊为孤立性脊髓MS,他接受了手术减压,随后局部照射,全身化疗和骨髓移植。然而,术后8个月,他经历了移植物抗宿主排斥反应,需要额外的治疗。结论:建立MS的诊断是具有挑战性的,通常需要组织学证实(即,骨髓母细胞和粒细胞的存在)。然而,最佳的治疗策略仍然难以捉摸;尽管放疗、化疗、骨髓移植/其他局部治疗,MS的整体长期预后仍然很差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A rare case of spinal myeloid sarcoma.

Background: Myeloid sarcoma (MS), a rare extramedullary tumor composed of myeloid blast cells, is classified by the World Health Organization as a subtype of acute myeloid leukemia (AML). Isolated, primary, or nonleukemic MS has an incidence of 2/1,000,000 adults and constitutes only 0.7% of all AML cases. MS presentations vary widely, with spinal involvement being rare.

Case description: A-year-old male presented with interscapular pain radiating to the right upper arm/neck but was neurologically intact. Once diagnosed with isolated spinal MS, he underwent a surgical decompression followed by local irradiation, systemic chemotherapy, and bone marrow transplantation. Eight months postoperatively, however, he experienced a graft-versus-host rejection and required additional therapies.

Conclusion: Establishing the diagnosis of MS is challenging and typically requires histological confirmation (i.e., the presence of myeloblasts and granulocytic cells). However, optimal treatment strategies remain elusive; despite radiation, chemotherapy, bone marrow transplant/other local therapies, the overall long-term prognosis for MS remains poor.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信